Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
TTM Technologies has rallied 8% on the week to $132.71, yet the stock trades at a steep discount to where its own analysts think it should be, a gap that becomes the central question ahead of a October 28 earnings print.
The most striking feature of the current setup is that unanimous analyst optimism has not stopped the stock from sitting nearly 37% below the average Street price target of $209.60. Every covering analyst carries a Buy rating, four in total, and targets have been raised repeatedly this year. Truist Securities lifted its target to $224 after the Q2 print in August, while Needham trimmed back to $175 in September, the only softening note in an otherwise bullish chorus. That Needham cut came on a maintained Buy, suggesting confidence in the direction but less certainty about the pace. The bull case rests on a $1.7 billion aerospace and defence backlog, a book-to-bill of 1.49x in Q2, and data centre and networking sales that ran 91% above year-ago levels. The bear case points to a valuation already pricing in the optimism at roughly 20x trailing earnings and 14.5x EV/EBITDA, plus integration risk from the EPIQ acquisition and potential demand fragility if tariff-driven caution spreads through the supply chain. Factor scores are mixed: earnings momentum over 90 days ranks in the 85th percentile, a genuinely strong reading, but the forward EPS growth rank sits at just 38, and the EV/EBIT score places in the 26th percentile, reflecting those stretched multiples.
Positioning in the lending and options markets tells a relaxed story. Short interest amounts to 3.3% of the free float, roughly 3.4 million shares, and has actually declined about 1.7% on the week even as the stock rallied. The month-on-month increase of 20% in shares short is worth noting in context: the absolute level remains modest. Borrowing costs are minimal at 0.47%, and availability is extraordinarily loose, with shares available to borrow running at roughly 70 times the current short position. The ORTEX short score of 32.2 places TTMI in the lower-conviction tier for short-side interest, and that reading has been essentially flat for the past two weeks. Options positioning echoes the lack of urgency. The put/call ratio at 0.46 is marginally below its 20-day average of 0.48, a Z-score of negative 0.43, meaning traders are not reaching for downside protection into the print. The PCR has drifted lower since mid-September, when it was running closer to 0.55, consistent with the stock's recovery over that same period.
One institutional data point worth flagging: Norges Bank Investment Management added a brand-new position of 1.27 million shares as of June 30, and Wellington Management built a holding of 867,000 shares in the same period. Both entries arrived when the stock was trading well above current levels, given the year-to-date journey. BlackRock, the largest holder at 10.4% of shares, added 198,000 shares as recently as September 30. The insider picture is more nuanced. CEO Edwin Roks made an open-market purchase of 10,000 shares at $111.77 on August 25, a clean discretionary buy worth just over $1.1 million, with no 10b5-1 plan attached. That followed a director purchase of 5,000 shares at $104.90 the day before. The net 90-day insider position is negative, driven by an SVP sale of 26,198 shares at $142 in August, but the CEO and director purchases at lower prices stand as the more signal-rich events.
Wikipedia attention for TTM has been running about 1.7 standard deviations above its own 90-day baseline, a useful gauge of retail and general investor interest rather than a financial indicator. No alt-data dataset has been measured to lead the company's reported figures, so the attention spike is colour rather than a forward read.
TTMI's close peers had a solid week. KEYS gained 7.6% and AEIS rose 6.9%, while JBL was the outlier, slipping 3%. The broad sector tailwind suggests TTMI's 8% week was not entirely idiosyncratic. Prior earnings prints offer a useful frame: the two most recent reports produced a 2.7% and 6.3% one-day gain respectively, with the earlier of the two extending to a 20.8% five-day move. The next print on October 28 will test whether the data centre and networking revenue run-rate and the backlog conversion story can close any part of the gap between the $132 price and the $209 consensus target, or whether analysts begin to follow Needham's September move and bring targets down toward the stock.
See the live data behind this article on ORTEX.
Open TTMI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
